San Antonio sisters Harper and Heidi Gaffney were born with dilated cardiomyopathy, a disease of the heart muscle. When they ...

PONTE VEDRA, Fla.--(BUSINESS WIRE)--Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a late-stage biopharmaceutical company focused on the development of specialized cardiovascular therapeutics, with the ...

ANN ARBOR, Mich. — A cardiac surgery and heart failure team at the University of Michigan implanted a novel mechanical heart pump into a patient as part of a clinical trial that will compare it to the ...

A cardiac surgery and heart failure team at the University of Michigan implanted a novel mechanical heart pump into a patient as part of a clinical trial that will compare it to the only device ...

In patients with LVADs, following allocation system changes in 2018, heart transplant waitlist mortality decreased. Heart transplant (HT) waitlist mortality was reduced in patients with a left ...

ACC Impella Pump Takes Positive Turn in Cardiogenic Shock Study After the Impella heart pump showed no added benefit in cardiogenic shock over less costly balloon pumps in prior studies, applying best ...

Abbott Laboratories, Inc. ABT recently announced that the FDA has approved a change of label for its HeartMate 3 left ventricular assist device (LVAD or heart pump). The development, meant exclusively ...

You might not realize just how necessary heart pumps are, especially if you’ve never had a heart issue or had someone you love struggle with it. These tiny dynamos are a lifeline in helping a failing ...

The Heartmate pump provides short- or long-term circulatory support for heart failure patients. The device takes over pumping for the left ventricle, the heart’s main pumping chamber. It can be used ...

The HeartMate 3 LVAD. [Image courtesy of Abbott] The FDA deemed another recall of the Abbott (NYSE: ABT) + HeartMate 3 system Class I, the most serious kind. Abbott’s latest HeartMate troubles are ...